Executive Summary
In the complex landscape of threat intelligence and research, understanding the tools used by threat actors is just as critical as identifying the actors themselves. How do we link specific malware to its…
Category: 6. Business
-
Unlock your brand visibility in the AI era with Ipsos Synthesio GEO
Consumers increasingly trust LLMs for category knowledge and brand recommendations, but most organisations remain unaware of how they are represented in these responses. The rise of large language models (LLMs) such as…
Continue Reading
-
AI for Knee Osteoarthritis Grading
Reader Performance Improved Across Experience Levels
As compared to a reference standard of the majority vote of three musculoskeletal radiology consultants, the researchers found that AI assistance increased the KL grading performance…
Continue Reading
-
Breakthrough Advances Sodium-Based Battery Design
“We’re delighted to be part of this project,” says UC San Diego Professor Shyue Ping Ong, “and apply our group’s latest advances in AI and machine learning for materials science to gain critical new…
Continue Reading
-
Blackstone Announces Intra-Quarter Realization Update Relating to the Third Quarter
NEW YORK – September 24, 2025 – Blackstone today announced its estimate of revenue related to realization activity for the period from July 1, 2025 to September 24, 2025. This estimate does not include revenue from any…
Continue Reading
-
Health Care, Finance, and Global Markets: Inside Tuck’s 2025 MBA First-Year Projects
by Adam Sylvain
Sep 24, 2025A hallmark of the Tuck MBA curriculum, the required First-Year Project (FYP) course provides a unique opportunity for students to put their leadership skills and…
Continue Reading
-
MaskMol: knowledge-guided molecular image pre-training framework for activity cliffs with pixel masking | BMC Biology
Fleming N. How artificial intelligence is changing drug discovery. Nature. 2018;557(7706):S55–S55.
Google Scholar
Zeng X, Wang F, Luo Y, Kang Sg, Tang J, Lightstone FC, et al. Deep…
Continue Reading
-
Dostarlimab Plus Chemo Expands Frontline Options in Advanced/Recurrent Endometrial Cancer
Following the August 2024 decision by the FDA to
expand the approval of dostarlimab-gxly (Jemperli) plus chemotherapy to include the frontline treatment of patients with primary advanced or recurrent endometrial cancer, patients now have greater…Continue Reading
-
Wall Street Says ‘Timeout Called’ as Rally Wanes: Markets Wrap
(Bloomberg) — Wall Street’s torrid surge from April’s meltdown is showing signs of exhaustion as stock traders…
Continue Reading
-
Common data elements for observational studies in ocular toxoplasmosis: a Delphi consensus | Journal of Ophthalmic Inflammation and Infection
In this study, we employed a Delphi method to achieve expert consensus on a comprehensive set of CDEs for the study of OT. The high response rate among uveitis experts with extensive clinical experience strengthens the validity of our findings….
Continue Reading